| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8237057 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 5 Pages |
Abstract
The results of our study have shown that weekly carboplatin at this dosage is a safe way to deliver synchronous chemotherapy during RT for MCC and results in a marked reduction of febrile neutropenia and Grade 3 skin toxicity compared with the three weekly regimen.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Michael F.R.A.N.Z.C.R., Euan F.R.A.C.P., Jennifer F.R.A.N.Z.C.R., Graeme F.R.A.N.Z.C.R., Peter F.R.A.N.Z.C.R., Jacqui B.Bus. (H.I.M.), Lee B.Sc., Danny F.R.A.N.Z.C.R.,